ORCL.NYSEOracle CORP

Form 4: Oracle Director Plans Future Stock Sale Under 10b5-1

Sentiment:

Insider Transaction Report


Oracle Corp. Director William G. Parrett reported a planned future sale of 11,500 shares of common stock at $306 per share under a Rule 10b5-1 plan.

Summary

  • William G. Parrett, a Director of Oracle Corp. (ORCL), reported a planned transaction.
  • The transaction involves the disposition (sale) of 11,500 shares of Oracle Common Stock.
  • The planned transaction date is September 12, 2025.
  • The shares are to be sold at a price of $306 per share.
  • Following this planned transaction, Mr. Parrett will beneficially own 17,764 shares indirectly through a Trust and 9,311 shares directly.
  • The transaction is being made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan.

Sentiment

Score: 6

Explanation: The transaction is a pre-planned future sale by a director under a Rule 10b5-1 plan, which typically indicates a scheduled divestment rather than a reaction to immediate company performance or outlook. This mitigates potential negative sentiment associated with insider sales.

Positives

  • The transaction is part of a pre-arranged Rule 10b5-1 trading plan, indicating a scheduled divestment rather than a reaction to immediate non-public information or a change in company outlook.

Negatives

  • A director's planned sale of 11,500 shares, even if pre-scheduled, will reduce their direct ownership in the company.

Future Outlook

This filing reports a specific future transaction by a director and does not contain broader forward-looking statements or guidance regarding the company's overall performance or strategic direction.

Industry Context

NA

Stakeholder Impact

  • Shareholders may note the planned reduction in a director's direct ownership, though the 10b5-1 plan suggests it is a routine, pre-scheduled event rather than a signal of concern.

Key Dates

DateDescription
09/12/2025Date of planned transaction for the sale of common stock.
09/16/2025Date the Form 4 was signed by the reporting person's attorney-in-fact.

Recommendation

hold

A single, pre-planned future transaction by a director under a Rule 10b5-1 plan is generally not a strong enough signal to alter a fundamental investment thesis for Oracle. While it represents a reduction in direct insider ownership, the pre-scheduled nature suggests it's not based on new, material non-public information. Investors should consider broader company fundamentals and market conditions rather than this isolated event.

Keywords

Oracle, ORCL, Form 4, Insider Transaction, Director Sale, William G. Parrett, 10b5-1 Plan, Common Stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.